Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 501–600 of 1,004
Molecular mechanisms of synaptogenesis
Qi, C., Luo, L.-D., Feng, I., & Ma, S. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.939793 · Cited by 54
Emerging Pharmacotherapies for Neurodevelopmental Disorders
Wetmore, D. Z., & Garner, C. C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee3833 · Cited by 54
Shank Modulates Postsynaptic Wnt Signaling to Regulate Synaptic Development
Harris, K. P., Akbergenova, Y., Cho, R. W., Baas-Thomas, M. S., & Littleton, J. T. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4279-15.2016 · Cited by 66
“The observation of synapse loss in heterozygotes of the Shank null allele is significant, because haploinsufficiency of SHANK3 is well established as a monogenic cause of ASD (Betancur and Buxbaum, 2013).”
BackgroundInfluentialGilbert, J. P., O’Connor, M. G., Templet, S., Moghaddam, M., Ioschpe, A. D. V., Sinclair, A., Zhu, L., Xu, W., & Man, H. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0222-19.2019 · Cited by 57
“…these genes, a large number play roles in the development and function of synapses, such as neuroligin 3 (NLGN3), neuroligin 4X (NLGN4X), neurexin 1 (NRXN1), and SH3 and multiple ankyrin repeat domains 3 (SHANK3) (Jamain et al., 2003; Feng et al., 2006; Durand et al., 2007; Tabuchi et al., 2007).”
BackgroundCerebral organoids as tools to identify the developmental roots of autism
Chan, W. K., Griffiths, R., Price, D. J., & Mason, J. O. (2020) · Molecular Autism · doi:10.1186/s13229-020-00360-3 · Cited by 62
“Subsequently, SHANK3 mutations have been found in numerous ASD patients [37, 50, 95].”
BackgroundN -Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
Ahmed, H., Haider, A., & Ametamey, S. M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1811234 · Cited by 60
“The human genes SHANK3 and SAPAP3 showed high degree of association with ASD and OCD, respectively [235,236].”
Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
Nadeem, M. S., Hosawi, S. B. I., Alshehri, S., Ghoneim, M. M., Imam, S. S., Murtaza, B. N., & Kazmi, I. A. (2021) · Biomolecules · doi:10.3390/biom11111635 · Cited by 63
Hussein, Y., Tripathi, U., Choudhary, A., Nayak, R., Peles, D., Rosh, I., Rabinski, T., Djamus, J., Vatine, G. D., Spiegel, R., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02535-x · Cited by 58
“Mutations in this gene have been linked to de fi cits in synaptic function and plasticity, accompanied by lower reciprocal social interactions [18, 20 – 23], ASD, and other neurodevelopmental symptoms [21, 24].”
Schmeisser, M. J., Grabrucker, A. M., Bockmann, J., & Boeckers, T. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020628 · Cited by 53
Self-citationPeng, Y. W., Lu, Z., Li, G., Piechowicz, M., Anderson, M. J., Uddin, Y., Wu, J., & Qiu, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.182 · Cited by 61
Shonesy, B. C., Parrish, W. P., Haddad, H. K., Stephenson, J. R., Báldi, R., Bluett, R. J., Marks, C. R., Centanni, S. W., Folkes, O. M., Spiess, K., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.036 · Cited by 55
Lanz, T. A., Guilmette, E., Gosink, M. M., Fischer, J. E., Fitzgerald, L. W., Stephenson, D. T., & Pletcher, M. T. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-45 · Cited by 52
“SH3 and multiple ankyrin repeat domains 3 (Shank3) Scaffold protein Synaptic Rare single gene mutation associated with autism symptom domains [12,29] Lanz et al.”
BackgroundComparing the Gut Microbiome in Autism and Preclinical Models: A Systematic Review
Alamoudi, M. U. A., Hosie, S., Shindler, A. E., Wood, J. L., Franks, A. E., & Hill‐Yardin, E. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905841 · Cited by 62
Dendritic mRNA Targeting and Translation
Kindler, S., & Kreienkamp, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_13 · Cited by 59
Volders, K., Nuytens, K., & Creemers, J. W. M. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243432 · Cited by 60
Autism: A review of biological bases, assessment, and intervention.
Volker, M. A., & Lopata, C. J. (2008) · School Psychology Quarterly · doi:10.1037/1045-3830.23.2.258 · Cited by 75
“3; Durand et al., 2007) genes have separately been associated with a small number of autism cases.”
BackgroundMameza, M. G., Dvoretskova, E., Bamann, M., Hönck, H.-H., Güler, T., Boeckers, T. M., Schoen, M., Verpelli, C., Sala, C., Barsukov, I., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424747 · Cited by 52
“It is generally understood that haploinsufficiency of the SHANK3 gene causesmental illness, eithermanifest as intellectual disability in case of the 22q13 deletion syndrome (34) or as autism (3).”
BackgroundSelf-citationCocks, G. D., Curran, S. R., Gami‐Patel, P., Uwanogho, D., Jeffries, A. R., Kathuria, A., Lucchesi, W., Wood, V. H. J., Dixon, R., Ogilvie, C. M., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3196-4 · Cited by 52
Links between genetics and pathophysiology in the autism spectrum disorders
Holt, R., & Monaco, A. P. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100157 · Cited by 61
“Marshall et al also found an increase in the percentage of de novo CNVs in families with one affected child and implicated post-synaptic density genes such as SHANK3, NLGN4 and NRXN1, as well as other genes encoding proteins in the synaptic complex, such as DPP10 (Marshall et al, 2008).”
BackgroundResultInfluentialAmiet, C., Gourfinkel-An, I., Laurent, C., Bodeau, N., Génin, B., Leguern, E., Tordjman, S., & Cohen, D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-47 · Cited by 52
“3 Deletion De novo ASD, ID, SCZ Synapse scaffolding [53,54]”
BackgroundEltokhi, A., Santuy, A., Merchán-Pérez, Á., & Sprengel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010059 · Cited by 60
Qin, L., Ma, K., & Yan, Z. (2019) · iScience · doi:10.1016/j.isci.2019.06.014 · Cited by 51
Michetti, C., Falace, A., Benfenati, F., & Fassio, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105856 · Cited by 58
Updated consensus guidelines on the management of Phelan–McDermid syndrome
Srivastava, S., Şahin, M., Buxbaum, J. D., Berry‐Kravis, E., Soorya, L. V., Thurm, A. E., Bernstein, J. A., Asante‐Otoo, A., Bennett, W. E., Betancur, C., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63312 · Cited by 55
Self-citationDevelopmental Disruptions of the Dorsal Striatum in Autism Spectrum Disorder
Evans, M. M., Kim, J., Abel, T. G., Nickl‐Jockschat, T., & Stevens, H. E. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.08.015 · Cited by 60
Studying Autism in Rodent Models: Reconciling Endophenotypes with Comorbidities
Argyropoulos, A., Gilby, K. L., & Hill‐Yardin, E. L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00417 · Cited by 54
“…proteins; ProSAPs) contains three members; Shank1-3 that code for post-synaptic scaffolding proteins involved in the recruitment of several receptors and proteins (including the neuroligins and neurexins) and ASD ( Nesslinger et al., 1994; Bonaglia et al., 2006; Durand et al., 2007).”
BackgroundFragile x syndrome and autism: from disease model to therapeutic targets
Dölen, G., & Bear, M. F. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9015-x · Cited by 51
“2, a number of other synaptic proteins that interact with the mGluRs either by direct physical contact or biochemical cascades, have also been identified as autism candidate genes [121–126] or single gene disorders associated with autism [127–134].”
Mutant Mouse Models of Autism Spectrum Disorders
Provenzano, G., Zunino, G., Genovesi, S., Sgadó, P., & Bozzi, Y. (2012) · Disease Markers · doi:10.1155/2012/916082 · Cited by 60
Neurogenetics: Advancing the “Next-Generation” of Brain Research
Zoghbi, H. Y., & Warren, S. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.015 · Cited by 48
“…or cognitive deficits, dystonia, and seizures (Partington syndrome) (Shoubridge et al., 2010), as well as the SHANK3 gene, whose mutations can cause Phelan McDermid syndrome, Asperger syndrome, autism, and rare cases of schizophrenia (Durand et al., 2007; Gauthier et al., 2010; Phelan, 2008).”
Pizzarelli, R., & Cherubini, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00085 · Cited by 50
“…(NL; Jamain et al., 2003; Laumonnier et al., 2004; Yan et al., 2005), neurexin (Nrx; Kim et al., 2008) families or for SHANK3, a scaffold protein involved in the structural organization of dendritic spines and a binding partner of NLs (Durand et al., 2007), have received particular attention.”
BackgroundInfluentialAbsence of strong strain effects in behavioral analyses of Shank3-deficient mice
Drapeau, E., Dorr, N. P., Elder, G. A., & Buxbaum, J. D. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013821 · Cited by 50
“…disorder (ASD), as well as hypotonia and other motor deficits, seizures, minor dysmorphic features and additional medical issues (Wilson et al., 2003; Bonaglia et al., 2006; Cusmano-Ozog et al., 2007; Durand et al., 2007; Moessner et al., 2007; Phelan, 2008; Herbert, 2011; Soorya et al., 2013).”
BackgroundThe emerging roles of MicroRNAs in autism spectrum disorders
Fregeac, J., Colleaux, L., & Nguyen, L. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.018 · Cited by 54
Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases
Sundararajan, T., Manzardo, A. M., & Butler, M. G. (2017) · Gene · doi:10.1016/j.gene.2017.10.035 · Cited by 58
“Disruption of the SHANK3 gene is found in Phelan-McDermid syndrome which is characterized by neonatal hypotonia, global developmental delay, growth deficit, severely delayed speech, autistic-like behavior and dysmorphic features (Durand et al., 2007).”
BackgroundHuang, G., Chen, S., Chen, X., Zheng, J., Xu, Z., Torshizi, A. D., Gong, S., Chen, Q., Ma, X., Yu, J., et al. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00023 · Cited by 64
MET Receptor Tyrosine Kinase as an Autism Genetic Risk Factor
Peng, Y., Huentelman, M., Smith, C., & Qiu, S. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00005-8 · Cited by 49
Neural circuit pathology driven by Shank3 mutation disrupts social behaviors
Kim, S., Kim, Y.-E., Song, I., Ujihara, Y., Kim, N., Jiang, Y., Yin, H. H., Lee, T., & Kim, I. H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110906 · Cited by 58
“Shank3 deficiency represents a monogenic ASD risk factor involved in about 1% of individuals with ASD (Moessner et al., 2007; Leblond et al., 2014; Durand et al., 2007).”
BackgroundGenetics of obesity and overgrowth syndromes
Sabin, M. A., Werther, G. A., & Kieß, W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.09.010 · Cited by 58
Epac2-mediated dendritic spine remodeling: Implications for disease
Penzes, P., Woolfrey, K. M., & Srivastava, D. P. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.11.008 · Cited by 49
“This notion is supported by the modulatory effect on spine morphology of several autism-associated proteins including the synaptic adhesion proteins NL3 and 4 and the postsynaptic scaffolding proteins Shank2 and 3 (Berkel et al., 2010; Chih et al., 2004; Durand et al., 2007; Tabuchi et al., 2007).”
BackgroundDoelken, S. C., Köhler, S., Mungall, C., Gkoutos, G. V., Ruef, B. J., Smith, C. L., Smedley, D. P., Bauer, S., Klopocki, E., Schofield, P. N., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010322 · Cited by 52
“Phelan-Mcdermid syndrome Major gene: SHANK3 (Durand et al., 2007) SHANK3 was recovered; additional candidates”
BackgroundA systematic variant annotation approach for ranking genes associated with autism spectrum disorders
Larsen, E., Menashe, I., Ziats, M. N., Pereanu, W., Packer, A., & Banerjee-Basu, S. (2016) · Molecular Autism · doi:10.1186/s13229-016-0103-y · Cited by 49
“SHANK3 was first reported as an ASD candidate gene based on identification of heterozygous mutations in ASD probands from three unrelated families [24].”
BackgroundThe Yin and Yang of Autism Genetics: How Rare De Novo and Common Variations Affect Liability
Chaste, P., Roeder, K., & Devlin, B. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022647 · Cited by 61
“Identification of the first X-linked or de novo mutations for nonsyndromic ASD (44, 71), together with the inconsistency of association studies based on selected candidate genes (1), reasonably cast doubt on the polygenic model and its assumptions.”
BackgroundSelf-citationShank Proteins Differentially Regulate Synaptic Transmission
Shi, R., Redman, P. T., Ghose, D., Hwang, H., Liu, Y., Ren, X., Ding, L. J., Liu, M., Jones, K. J., & Xu, W. (2017) · eNeuro · doi:10.1523/eneuro.0163-15.2017 · Cited by 56
“To produce the lentiviruses, the transfer vectors and the HIV-1 packaging vectors (pRSV/REV, pMDLg/pRRE, and the VSV-G envelope glycoprotein vector (Dull et al., 1998) were cotransfected into HEK293T fibroblasts (ATCC, RRID: CVCL_0063) using the FUGENE6 transfection reagent (Promega).”
MethodYoo, T., Cho, H., Lee, J., Park, H., Yoo, Y.-E., Yang, E., Kim, J. Y., Kim, H., & Kim, E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00341 · Cited by 46
Sabitha, K. R., Shetty, A. K., & Upadhya, D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.025 · Cited by 60
“The majority of the deletions in this region include SHANK3 gene that encodes synaptic scaffolding proteins located at glutamatergic synapses connecting membrane-bound receptors to the actin cytoskeleton (Durand et al., 2007; Phelan, 2008; Gong et al., 2012; Phelan and McDermid, 2012; Monteiro and Feng, 2017).”
BackgroundMolecular and synaptic defects in intellectual disability syndromes
Verpelli, C., & Sala, C. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.007 · Cited by 65
“Loss of Shank3 is now considered to cause the neurobehavioral symptoms of PMS, although other genes may also be lost [52,54,56,57].”
BackgroundTabor, H. K., & Cho, M. K. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e3181485688 · Cited by 55
Kawanai, T., Ago, Y., Watanabe, R., Inoue, A., Taruta, A., Onaka, Y., Hasebe, S., Hashimoto, H., Matsuda, T., & Takuma, K. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1969-y · Cited by 49
Lee, Y., Kim, S. G., Lee, B., Zhang, Y., Kim, Y., Kim, S., Kim, E., Kang, H., & Han, K. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00201 · Cited by 49
“We found that among the eight major classes of psychiatric disorders in the PsyGeNET, ‘‘BDs and related disorders’’ and ‘‘SCZ spectrum and other psychiatric disorders’’ were significantly associated with the 94 genes of Shank3-mTORC1 interactome (adjusted P = 0.000186 for both, hypergeometric test; Figures 4A,B and Su…”
BackgroundInfluentialJin, Z., Li, Z., Liu, Z., Jiang, Y. W., Cai, X., & Wu, J. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12383 · Cited by 55
“…DNM in the SHANK3 gene in two ASD probands from the same family; this DNM was verified to be of maternal origin but absent from somatic tissue samples of the mother, indicating germline mosaicism Biological Reviews 93 (2018) 1014–1031 © 2017 Cambridge Philosophical Society (Durand et al., 2007).”
BackgroundInfluentialDiscovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms
Uzun, E. D. G., Sciarra, L. N., Maguire, A. M., Pescosolido, M. F., van Dyck, L. I., & Morrow, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0363-9 · Cited by 50
“Furthermore, SHANK3 is also considered a major effect locus in autism [153, 154], with deletions found in at least 0.”
BackgroundSaupe, J., Roske, Y., Schillinger, C., Kamdem, N., Radetzki, S., Diehl, A., Oschkinat, H., Krause, G., Heinemann, U., & Rademann, J. (2011) · ChemMedChem · doi:10.1002/cmdc.201100094 · Cited by 52
Toma, C., Hervas, A., Balmaña, N., Salgado, M., Maristany, M., Vilella, E., Aguilera, F., Orejuela, C., Cuscó, I., Gallastegui, F., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602719 · Cited by 53
The Social Brain Network and Autism
Misra, V. (2014) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.210208 · Cited by 52
“33 mutations, deletions Structural and functional organization of the dendritic spine and synaptic junction Phelan-Mcdermid syndrome, ASds, schizophrenia (29, 36-38)”
BackgroundGong, X., Jiang, Y.-W., Zhang, X., An, Y., Zhang, J., Wu, Y., Wang, J., Sun, Y., Liu, Y., Gao, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034739 · Cited by 46
“firstly sequenced all SHANK3 exons in autism spectrum disorders (ASDs) and found a frameshift mutation in one ASD individual [11].”
BackgroundGenome-wide disruption of 5-hydroxymethylcytosine in a mouse model of autism
Papale, L. A., Zhang, Q., Li, S., Chen, K., Keleş, S., & Alisch, R. S. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv411 · Cited by 52
Autism Spectrum Disorder - A Complex Genetic Disorder
Ivanov, H. Y., Stoyanova, V. K., Popov, N. T., & Vachev, T. I. (2015) · Folia Medica · doi:10.1515/folmed-2015-0015 · Cited by 45
Colonic dilation and altered ex vivo gastrointestinal motility in the neuroligin‐3 knockout mouse
Leembruggen, A. J. L., Balasuriya, G. K., Zhang, J., Schokman, S., Swiderski, K., Bornstein, J. C., Nithianantharajah, J., & Hill‐Yardin, E. L. (2019) · Autism Research · doi:10.1002/aur.2109 · Cited by 50
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Markopoulos, A., Inserra, A., De Gregorio, D., & Gobbi, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749068 · Cited by 46
Egger, J. I. M., Zwanenburg, R. J., van Ravenswaaij‐Arts, C. M. A., Kleefstra, T., & Verhoeven, W. M. A. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12285 · Cited by 45
“…structures of the central nervous system (Bonaglia et al. 2001; Guilmatre et al. 2014; Jamain et al. 2003) and is likely to be responsible for the clinical features of the disorder especially for the development of language and social communication (Bonaglia et al. 2006; Durand et al. 2007).”
BackgroundZhang, Z., & Sun, Q. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-385198-7.00012-6 · Cited by 56
Shank1 mRNA: Dendritic Transport by Kinesin and Translational Control by the 5′Untranslated Region
Falley, K., Schütt, J., Iglauer, P., Menke, K., Maas, C., Kneussel, M., Kindler, S., Wouters, F. S., Richter, D., & Kreienkamp, H. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00912.x · Cited by 49
“Haploinsufficiency for the Shank3 gene is associated with mental retardation or autism in human patients (25,26).”
BackgroundFujita‐Jimbo, E., Tanabe, Y., Yu, Z., Kojima, K., Mori, M., Li, H., Iwamoto, S., Yamagata, T., Momoi, M. Y., & Momoi, T. (2015) · Molecular Autism · doi:10.1186/s13229-015-0012-5 · Cited by 51
“Other studies of pedigrees that harbor mutations in SHANK3, CNTNAP2, MECP2, MBD1, or CADM1 have also reported that unaffected parents of either gender can carry an ASD-associated mutation [2-4,27,28].”
BackgroundAn opposing function of paralogs in balancing developmental synapse maturation
Favaro, P. D., Huang, X., Hosang, L., Stodieck, S. K., Cui, L., Liu, Y.-Z., Engelhardt, K.-A., Schmitz, F., Dong, Y., Löwel, S., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006838 · Cited by 47
Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders
Parra‐Damas, A., & Saura, C. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.006 · Cited by 55
Molecular mechanisms of dendritic spine development and maintenance [Review]
Sala*, C., Cambianica, I., & Rossi, F. (2008) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2008-1696 · Cited by 45
Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome
Schön, M., Lapunzina, P. D., Nevado, J., Mattina, T., Gunnarsson, C., Hadzsiev, K., Verpelli, C., Bourgeron, T., Jesse, S., van Ravenswaaij‐Arts, C. M. A., et al. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104754 · Cited by 53
“…for SHANK3 ; 4) Balanced translocations with a breakpoint in SHANK3 (Bonaglia et al., 2001), and intragenic variants, here termed SHANK3 variants (Durand et al., 2006), exhibit some of the common features and severe manifestations (including language impairment, intellectual disability (ID),…”
BackgroundSelf-citationCopy number variants in adult patients with Lennox–Gastaut syndrome features
Lund, C., Brodtkorb, E., Røsby, O., Rødningen, O. K., & Selmer, K. K. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.01.009 · Cited by 48
Beyond categorical diagnostics in psychiatry: Scientific and medicolegal implications
Anckarsäter, H. S. (2010) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2009.12.001 · Cited by 58
Self-citationGenetic diagnosis of autism spectrum disorders: The opportunity and challenge in the genomics era
Jiang, Y., Wang, Y., Xu, X., Choy, K. W., Pursley, A. N., & Cheung, S. W. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.910747 · Cited by 51
Jonsson, L., Zettergren, A., Pettersson, E., Hovey, D., Anckarsäter, H., Westberg, L., Lichtenstein, P., Lundström, S., & Melke, J. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-55 · Cited by 44
“In SHANK3, mainly rare genetic variations have been identified in subjects with ASD [14] and association analysis for rs9616915 has previously shown negative results for association with ASD in both European and Han Chinese populations [26].”
BackgroundResultSelf-citationSpecific Roles of NMDA Receptor Subunits in Mental Disorders
Yamamoto, H., Hagino, Y., Kasai, S., & Ikeda, K. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330142807 · Cited by 56
“Rare mutations in SHANK3 have been reported in patients with idiopathic ASD [60, 61].”
BackgroundDefects in translational regulation contributing to human cognitive and behavioral disease
Darnell, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.05.002 · Cited by 43
“Again, Shank3 is a good example; duplication of the 22q13 region encompassing the Shank3 gene has been linked to severe impairment of social communication [4].”
BackgroundCell Adhesion Molecules and Their Involvement in Autism Spectrum Disorder
Ye, H., Liu, J., & Wu, J. Y. (2010) · Neurosignals · doi:10.1159/000322543 · Cited by 49
“(fig. 2 ). SHANK binds to neuroligins directly or indirectly in the postsynaptic density (PSD). The human SHANK3 gene is located on chromosome 22q13, a region deleted or amplified in some ASD patients [”
BackgroundInduced pluripotent stem cells for modeling neurological disorders
Russo, F. B., Cugola, F. R., Fernandes, I. R., Pignatari, G. C., & Beltrão-Braga, P. C. B. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i4.209 · Cited by 48
Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure
Seifuddin, F., Wand, G., Cox, O., Pirooznia, M., Moody, L., Yang, X., Tai, J., Boersma, G., Tamashiro, K., Zandi, P., et al. (2017) · Epigenetics · doi:10.1080/15592294.2017.1334025 · Cited by 43
de Chaumont, F., Lemière, N., Coqueran, S., Bourgeron, T., & Ey, E. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.735920 · Cited by 50
Self-citationBanerjee, A., Luong, J. A., Ho, A., Saib, A. O., & Ploski, J. E. (2016) · Molecular Autism · doi:10.1186/s13229-016-0077-9 · Cited by 43
“Synaptic abnormalities have been observed in fragile X [37, 38], Rett syndrome [39], Angelman syndrome [40], and tuberous sclerosis complex [41–43].”
BackgroundRANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer
Rao, S., Sigl, V., Wimmer, R., Novatchkova, M., Jaïs, A., Wagner, G., Handschuh, S., Uribesalgo, I., Hagelkrüys, A., Kozieradzki, I., et al. (2017) · Genes & Development · doi:10.1101/gad.304162.117 · Cited by 43
Jung, S., & Park, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106340 · Cited by 42
Zhao, F., Zhang, H., Wang, P., Cui, W., Xu, K., Chen, D., Hu, M., Li, Z., Geng, X., & Wei, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.919890 · Cited by 44
SpliceTransformer predicts tissue-specific splicing linked to human diseases
You, N., Liu, C., Gu, Y., Wang, R., Jia, H., Zhang, T., Jiang, S., Shi, J., Chen, M., Guan, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53088-6 · Cited by 60
“We also found SHANK3 , a scaffolding protein found in excitatory synapses, which has been reported to be associated with severecognitive de fi cits including language and speech disorder and ASD 51 .”
InfluentialYang, K., Cao, F., Sheikh, A. M., Malik, M. N., Wen, G. Y., Wei, H., Brown, W. T., & Li, X. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0420-7 · Cited by 45
“…proteins including NRXN1, NLGN3/4, CNTNAP2, CACNA1C, and PCDH9/10 in autism and suggest that synaptic abnormalities could significantly contribute for the development of autism (Zoghbi 2003; Belmonte and Bourgeron 2006; Canitano 2007; Durand et al. 2007; Szatmari et al. 2007; Kim et al. 2008).”
BackgroundLennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., Schulze‐Rauschenbach, S., Landsberg, M. W., Steinbrecher, A., Alexander, M., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0233-3 · Cited by 47
Hagmeyer, S., Sauer, A. K., & Grabrucker, A. M. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00011 · Cited by 45
“In several patients with autism, deletions, nonsense, missense and splice site mutations have been found that affect the function of one SHANK3 allele (Durand et al., 2007; Gauthier et al., 2009).”
Ponson, L., Gomot, M., Blanc, R., Barthélémy, C., Roux, S., Münnich, A., Romana, S. P., Aguillon-Hernandez, N., Malan, V., & Bonnet‐Brilhault, F. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0212-9 · Cited by 46
Home-cage hypoactivity in mouse genetic models of autism spectrum disorder
Angelakos, C. C., Tudor, J. C., Ferri, S. L., Jongens, T. A., & Abel, T. G. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.02.010 · Cited by 49
“SH3 and multiple Ankyrin repeat domains 3 (Shank3) is a scaffolding protein in the postsynaptic density whose deletion contributes to Phelan-McDermid syndrome, intellectual disability, and ASD-like behaviors in humans (Durand et al., 2007), and social deficits and repetitive behaviors in mice (Peça et al.”
BackgroundYoo, Y.-E., Yoo, T., Lee, S., Lee, J., Kim, D., Han, H.-M., Bae, Y.-C., & Kim, E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00155 · Cited by 44
Lin, C.-W., Chen, C.-Y., Cheng, S., Hu, H., & Hsueh, Y. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00087 · Cited by 45
“For example, all of the members of the Shank protein family that indirectly link NMDAR and mGluR were identified as autism causative genes (Durand et al., 2007; Hung et al., 2008; Berkel et al., 2010; Pinto et al., 2010; Peca et al., 2011; Sato et al., 2012; Schmeisser et al., 2012; Won et al.,…”
BackgroundAltered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Jacot-Descombes, S., Keshav, N. U., Dickstein, D. L., Wicinski, B., Janssen, W. G. M., Hiester, L. L., Sarfo, E. K., Warda, T., Fam, M. M., Harony-Nicolas, H., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-00393-8 · Cited by 41
Sex Hormones Regulate SHANK Expression
Berkel, S., Eltokhi, A., Fröhlich, H., Porras-Gonzalez, D., Rafiullah, R., Sprengel, R., & Rappold, G. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00337 · Cited by 41
“Nevertheless, it cannot be excluded that a general dysregulation of SHANK gene expression contributes to ASD pathology, as SHANK3 gene duplications have also been identified in individuals with Asperger syndrome (Durand et al., 2007).”
BackgroundDiverse mutational mechanisms cause pathogenic subtelomeric rearrangements
Luo, Y. Y., Hermetz, K. E., Jackson, J. M., Mullé, J. G., Dodd, A., Tsuchiya, K. D., Ballif, B. C., Shaffer, L. G., Cody, J. D., Ledbetter, D. H., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr293 · Cited by 47
“Subtelomeric rearrangement studies have also paved the way for the discovery of critical regions and genes responsible for specific phenotypes (14,15).”
BackgroundInsulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children
Riikonen, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102056 · Cited by 40
Yoo, T., Cho, H., Park, H., Lee, J., & Kim, E. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00458 · Cited by 49
Mesleh, A. G., Abdulla, S. A., & El‐Agnaf, O. M. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010041 · Cited by 47
Moutin, E., Sakkaki, S., Compan, V., Bouquier, N., Giona, F., Areias, J., Goyet, E., Hemonnot-Girard, A.-L., Seube, V., Glasson, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01230-x · Cited by 45
Philippi, A., Tores, F., Carayol, J., Rousseau, F., Letexier, M., Roschmann, E., Lindenbaum, P., Benajjou, A., Fontaine, K., Vazart, C., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-74 · Cited by 40
“Single mutations in neuroligin 3 and 4, cell adhesion molecules present at the post-synaptic side of the synapse, and in SHANK3, a scaffolding protein found in excitatory synapses, have been described in autistic individuals [6,7].”
BackgroundOrnoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Kantojärvi, K., Onkamo, P., Vanhala, R., Alen, R., Hedman, M., Sajantila, A., Nieminen-von Wendt, T., & Järvelä, I. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a2080 · Cited by 40
“…transporter (SLC6A4 or 5-HTT) gene (Conroy et al., 2004; Ramoz et al., 2006), the reelin (RELN) gene (Persico et al., 2001; Zhang et al., 2002; Skaar et al., 2005), SH3 and multiple ankyrin repeat domains 3 (SHANK3) (Durand et al., 2007) and the engrailed gene (EN2) (Benayed et al., 2005).”
BackgroundMolecular and Phenotypic Characterization of Ring Chromosome 22 in Two Unrelated Patients
Hannachi, H., Mougou-Zerelli, S., Benabdallah, I., Soayh, N., Kahloul, N., Gaddour, N., Lorc’h, M. L., Sanlaville, D., Elghezal, H., & Saad, A. (2013) · Cytogenetic and Genome Research · doi:10.1159/000350785 · Cited by 41
“…et al., 2009] confirmed the major role of this gene in neurobehavioral development and led to the suggestion that some SHANK3 gene variations could represent a risk for ASD, in conjunction with other susceptibility factors [Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009].”
BackgroundLiu, Y., Du, Y., Liu, W., Yang, C., Liú, Y., Wang, H., & Gong, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056639 · Cited by 47
“Rare de novo CNVs and nonsense/ frameshift mutations in SHANK2 and SHANK3 have been identified in ASD and mental retardation cases [9,10,26,27,34].”
Background
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.